CN108948114B - 一种应用于9-(e)-红霉素肟的去杂方法 - Google Patents
一种应用于9-(e)-红霉素肟的去杂方法 Download PDFInfo
- Publication number
- CN108948114B CN108948114B CN201811035266.4A CN201811035266A CN108948114B CN 108948114 B CN108948114 B CN 108948114B CN 201811035266 A CN201811035266 A CN 201811035266A CN 108948114 B CN108948114 B CN 108948114B
- Authority
- CN
- China
- Prior art keywords
- erythromycin oxime
- erythromycin
- oxime
- dichloromethane
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 29
- 239000012535 impurity Substances 0.000 title claims abstract description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 101
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- KYTWXIARANQMCA-PGYIPVOXSA-N (3r,4s,5s,6r,7r,9r,10z,11s,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-10-hydroxyimino-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradec Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N\O)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 KYTWXIARANQMCA-PGYIPVOXSA-N 0.000 claims abstract description 18
- 230000008569 process Effects 0.000 claims abstract description 14
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 239000003513 alkali Substances 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 239000012046 mixed solvent Substances 0.000 claims abstract description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 235000011121 sodium hydroxide Nutrition 0.000 claims description 2
- 238000005202 decontamination Methods 0.000 claims 5
- 230000003588 decontaminative effect Effects 0.000 claims 5
- 238000004064 recycling Methods 0.000 claims 1
- 239000012452 mother liquor Substances 0.000 abstract description 3
- 238000011084 recovery Methods 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000010865 sewage Substances 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 12
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 11
- 238000006146 oximation reaction Methods 0.000 description 7
- 238000003756 stirring Methods 0.000 description 5
- 229960003276 erythromycin Drugs 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- RXZBMPWDPOLZGW-XMRMVWPWSA-N (E)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960002626 clarithromycin Drugs 0.000 description 1
- AGOYDEPGAOXOCK-KCBOHYOISA-N clarithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@](C)([C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)OC)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 AGOYDEPGAOXOCK-KCBOHYOISA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229960005224 roxithromycin Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811035266.4A CN108948114B (zh) | 2018-09-06 | 2018-09-06 | 一种应用于9-(e)-红霉素肟的去杂方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811035266.4A CN108948114B (zh) | 2018-09-06 | 2018-09-06 | 一种应用于9-(e)-红霉素肟的去杂方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108948114A CN108948114A (zh) | 2018-12-07 |
CN108948114B true CN108948114B (zh) | 2021-08-17 |
Family
ID=64476017
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811035266.4A Active CN108948114B (zh) | 2018-09-06 | 2018-09-06 | 一种应用于9-(e)-红霉素肟的去杂方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108948114B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021084411A1 (en) * | 2019-10-29 | 2021-05-06 | Hikal Limited | Substantially pure clarithromycin 9-oxime and its preparation thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009007988A1 (en) * | 2007-07-11 | 2009-01-15 | Alembic Limited | Process for the preparation of 6-o-methylerythromycin a 9-oxime |
CN101362783A (zh) * | 2008-10-06 | 2009-02-11 | 浙江国邦药业有限公司 | 一种红霉素a(e)肟的制备方法 |
CN107987113A (zh) * | 2017-12-22 | 2018-05-04 | 宁夏启元药业有限公司 | 一种利用红霉素发酵液直接制备红霉素肟的方法 |
-
2018
- 2018-09-06 CN CN201811035266.4A patent/CN108948114B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009007988A1 (en) * | 2007-07-11 | 2009-01-15 | Alembic Limited | Process for the preparation of 6-o-methylerythromycin a 9-oxime |
CN101362783A (zh) * | 2008-10-06 | 2009-02-11 | 浙江国邦药业有限公司 | 一种红霉素a(e)肟的制备方法 |
CN107987113A (zh) * | 2017-12-22 | 2018-05-04 | 宁夏启元药业有限公司 | 一种利用红霉素发酵液直接制备红霉素肟的方法 |
Non-Patent Citations (2)
Title |
---|
红霉素A(E)肟的合成及其贝克曼重排反应;楼科侠;《中国优秀硕士学位论文全文数据库(电子期刊) 医药卫生科技辑》;20060615(第6期);正文第21、30、38-42页 * |
红霉素肟的合成新工艺;王俊臣,等;《山东化工》;20161231;第45卷(第15期);26-29 * |
Also Published As
Publication number | Publication date |
---|---|
CN108948114A (zh) | 2018-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2495329B1 (en) | Process for economically manufacturing xylose from hydrolysate using electrodialysis and direct recovery method | |
CN101486669A (zh) | 一种合成牛磺酸的方法 | |
CN1318391C (zh) | 从红辣椒中提取分离辣椒碱和辣椒红色素的方法 | |
CN106674292B (zh) | 一种三氯蔗糖水结晶母液的提纯处理方法 | |
CN104945289A (zh) | 一种用固体羟乙基磺酸钠制备牛磺酸的方法 | |
CN104710483B (zh) | 一种硫酸氨基葡萄糖的制备方法 | |
CN104262425B (zh) | 一种提取甜茶苷的方法 | |
WO2017121343A1 (zh) | 一种从工业废水中回收锂的工艺 | |
CN103242384A (zh) | 三氯蔗糖新型母液萃取工艺 | |
CN108948114B (zh) | 一种应用于9-(e)-红霉素肟的去杂方法 | |
CN106995398A (zh) | L‑脯氨酸提取新工艺 | |
CN112876527B (zh) | 一种醋酸泼尼松母液的处理方法 | |
CN109796347B (zh) | 无硝酸废水排出的二甲戊灵生产工艺 | |
CN106883227B (zh) | 通过麦角菌发酵废料制备麦角新碱的方法 | |
CN112250049A (zh) | 一种尿素法水合肼副产盐碱的分离方法 | |
CN104892370A (zh) | 一种还原型辅酶q10的制备方法 | |
CN101195594B (zh) | 一种从生产吐氏酸的废水中提取有效成分的制备方法 | |
CN108017504A (zh) | 正己烷的提纯方法 | |
CN101613311B (zh) | 从重排混合物中回收己内酰胺的系统和方法 | |
CN106916947A (zh) | 准分馏萃取分离硫酸锂中钠和钾的方法 | |
CN105061196A (zh) | 一种从柠檬酸钾末道母液中提纯柠檬酸钾的方法 | |
CN112225720A (zh) | 一种噻吩-2-乙酰氯的生产方法 | |
CN106518729A (zh) | 盐酸鲁拉西酮中间体的制备方法 | |
CN101824056B (zh) | 1,2,3-三-O-乙酰基-5-脱氧-β-D-核糖的制备方法 | |
CN111087373A (zh) | 一种酸法制备维生素c的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A impurity removal method applied to 9- (E) - erythromycin oxime Effective date of registration: 20230421 Granted publication date: 20210817 Pledgee: Bank of China Limited Huangshi Branch Pledgor: HUANGSHI SHIXING PHARMACEUTICAL Co.,Ltd. Registration number: Y2023420000174 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20210817 Pledgee: Bank of China Limited Huangshi Branch Pledgor: HUANGSHI SHIXING PHARMACEUTICAL Co.,Ltd. Registration number: Y2023420000174 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A impurity removal method applied to 9- (E) - erythromycin oxime Granted publication date: 20210817 Pledgee: Bank of China Limited Huangshi Branch Pledgor: HUANGSHI SHIXING PHARMACEUTICAL Co.,Ltd. Registration number: Y2024980013802 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |